New Vernon Capital Holdings II’s Dr. Reddy's Laboratories RDY Stock Holding History

New Vernon Capital Holdings II’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-580,790	Closed	-$8.28M	–	30
2020 Q4	$8.28M	Sell	580,790 -137,555	-19%	-$1.85M	2.61%	15
2020 Q3	$9.99M	Buy	718,345 +91,845	+15%	+$1.09M	3.67%	9
2020 Q2	$6.64M	Buy	626,500 +92,675	+17%	+$943K	3.59%	7
2020 Q1	$4.31M	Buy	533,825 +238,315	+81%	+$1.99M	3.72%	8
2019 Q4	$2.4M	Hold	295,510	–	–	1.35%	11
2019 Q3	$2.24M	Hold	295,510	–	–	1.54%	12
2019 Q2	$2.21M	Sell	295,510 -33,860	-10%	-$266K	1.6%	11
2019 Q1	$2.67M	Buy	329,370 +64,120	+24%	+$487K	2.02%	10
2018 Q4	$2M	Buy	+265,250	New	+$1.87M	3.09%	8
2018 Q2	–	Sell	-336,525	Closed	-$2.2M	–	51
2018 Q1	$2.2M	Hold	336,525	–	–	3.06%	13
2017 Q4	$2.53M	Buy	+336,525	New	+$2.42M	3.52%	12

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

New Vernon Capital Holdings II's RDY Position: Q1 2021 in Review

New Vernon Capital Holdings II sold out of Dr. Reddy's Laboratories (RDY) in Q1 2021, closing a stake of 580,790 shares — an estimated $8.28M sold.

New Vernon Capital Holdings II first reported a position in RDY in Q4 2017 and held it in 11 quarters. The position peaked at $9.99M in Q3 2020. 161 funds tracked by Wall St. Rank hold RDY as of Q1 2021.

New Vernon Capital Holdings II reported no remaining Dr. Reddy's Laboratories position as of Q1 2021 after selling out during the quarter.
New Vernon Capital Holdings II sold 580,790 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $8.28M.
New Vernon Capital Holdings II first reported a position in Dr. Reddy's Laboratories in Q4 2017 and held it in 11 quarters.
New Vernon Capital Holdings II's Dr. Reddy's Laboratories position peaked at $9.99M in Q3 2020.
161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.

Based on New Vernon Capital Holdings II's 13F filing for Q1 2021, filed 17 May 2021.